{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T08:48:10Z","timestamp":1794732490848,"version":"4.9.1"},"reference-count":106,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2001,12,24]],"date-time":"2001-12-24T00:00:00Z","timestamp":1009152000000},"content-version":"vor","delay-in-days":571,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2000,6]]},"abstract":"<jats:p>Alginate\u2010based raft\u2010forming formulations have been marketed word\u2010wide for over 30\u2003years under various brand names, including Gaviscon. They are used for the symptomatic treatment of heartburn and oesophagitis, and appear to act by a unique mechanism which differs from that of traditional antacids. In the presence of gastric acid, alginates precipitate, forming a gel. Alginate\u2010based raft\u2010forming formulations usually contain sodium or potassium bicarbonate; in the presence of gastric acid, the bicarbonate is converted to carbon dioxide which becomes entrapped within the gel precipitate, converting it into a foam which floats on the surface of the gastric contents, much like a raft on water. Both <jats:italic>in vitro<\/jats:italic> and <jats:italic>in vivo<\/jats:italic> studies have demonstrated that alginate\u2010based rafts can entrap carbon dioxide, as well as antacid components contained in some formulations, thus providing a relatively pH\u2010neutral barrier. Several studies have demonstrated that the alginate raft can preferentially move into the oesophagus in place, or ahead, of acidic gastric contents during episodes of gastro\u2010oesophageal reflux; some studies further suggest that the raft can act as a physical barrier to reduce reflux episodes. Although some alginate\u2010based formulations also contain antacid components which can provide significant acid neutralization capacity, the efficacy of these formulations to reduce heartburn symptoms does not appear to be totally dependent on the neutralization of bulk gastric contents.<\/jats:p><jats:p>The strength of the alginate raft is dependant on several factors, including the amount of carbon dioxide generated and entrapped in the raft, the molecular properties of the alginate, and the presence of aluminium or calcium in the antacid components of the formulation. Raft formation occurs rapidly, often within a few seconds of dosing; hence alginate\u2010containing antacids are comparable to traditional antacids for speed of onset of relief. Since the raft can be retained in the stomach for several hours, alginate\u2010based raft\u2010forming formulations can additionally provide longer\u2010lasting relief than that of traditional antacids. Indeed, clinical studies have shown Gaviscon is superior to placebo, and equal to or significantly better than traditional antacids for relieving heartburn symptoms.<\/jats:p><jats:p>Alginate\u2010based, raft\u2010forming formulations have been used to treat reflux symptoms in infants and children, and in the management of heartburn and reflux during pregnancy. While Gaviscon is effective when used alone, it is compatible with, and does not interfere with the activity of antisecretory agents such as cimetidine. Even with the introduction of new antisecretory and promotility agents, alginate\u2010rafting formulations will continue to have a role in the treatment of heartburn and reflux symptoms. Their unique non\u2010systemic mechanism of action provides rapid and long\u2010duration relief of heartburn and acid reflux symptoms.<\/jats:p>","DOI":"10.1046\/j.1365-2036.2000.00759.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T03:41:49Z","timestamp":1047354109000},"page":"669-690","source":"Crossref","is-referenced-by-count":209,"title":["Review article: alginate\u2010raft formulations in the treatment of heartburn and acid reflux"],"prefix":"10.1111","volume":"14","author":[{"family":"Mandel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Daggy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Brodie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Jacoby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2001,12,24]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"47","article-title":"Prevalence of symptoms of dyspepsia in the community","volume":"1","author":"Jones R","year":"1989","journal-title":"Lancet"},{"key":"e_1_2_6_3_2","first-page":"18","article-title":"Management algorithms for the primary care physician and the specialist","volume":"22","author":"Castell DO","year":"1998","journal-title":"Practical Gastroenterology"},{"key":"e_1_2_6_4_2","unstructured":"Anon.OTC Bulletin Feb 27 1998:147."},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1995.00430200044008"},{"key":"e_1_2_6_6_2","first-page":"145","article-title":"Functional dyspepsia: a classification with guidelines for diagnosis and management","volume":"4","author":"Talley NJ","year":"1991","journal-title":"Gastroenterol Intl"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1993.tb00101.x"},{"key":"e_1_2_6_8_2","unstructured":"JacobyHI&BrodieDA.Emerging Gastrointestinal Therapy Markets. Waltham MA: Decision Resources 1997."},{"key":"e_1_2_6_9_2","first-page":"653","article-title":"Symptomatic reflux esophagitis: a double\u2010blind controlled comparison of antacids and alginate","volume":"22","author":"Graham DY","year":"1977","journal-title":"Curr Therap Res"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007611-198603000-00017"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1997.113284000.x"},{"key":"e_1_2_6_12_2","first-page":"A206","article-title":"Comparison of cimetidine 100, 200, or 300\u2003mg, in preventing meal\u2013induced heartburn","volume":"12","author":"Friedman C","journal-title":"J Gastroenterol Hepatol"},{"key":"e_1_2_6_13_2","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1001\/archinte.1991.00400030018004","article-title":"Rationale and efficacy of conservative therapy for gastroesophageal reflux disease","volume":"11","author":"Kitchin LI","year":"1991","journal-title":"Arch Intern Med"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01798350"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1159\/000197991"},{"key":"e_1_2_6_16_2","unstructured":"KahrilasPJ.Gastroesophageal reflux disease and its complications. In: Feldman M et\u2003al. eds. Sleisenger and Fordtran\u2019s Gastrointestinal and Liver Disease 6th edn. New York USA: W.B. Saunders 1998: 498\u2013517."},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529509090286"},{"key":"e_1_2_6_18_2","first-page":"1739","article-title":"Mechanism of gastroesophageal acid reflux and esophageal acid clearance in heartburn","volume":"91","author":"Allen MI","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.3810\/pgm.1996.11.110"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1159\/000200911"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365528909091032"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.3109\/13814789509161628"},{"key":"e_1_2_6_23_2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1742-1241.1996.tb09543.x","article-title":"Heartburn, oesophagitis and Barrett\u2019s oesophagitis in self\u2010medication patients in general practice","volume":"50","author":"Corder AP","year":"1996","journal-title":"Br J Clin Pract"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(58)80023-2"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-96-3-320"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.34.7.872"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(92)91442-7"},{"key":"e_1_2_6_28_2","unstructured":"TierneyLM Jr McPheeSJ PapadakisMA eds.Current Medical Diagnosis and Treatment 3rd edn. Stanford CT USA: Appleton and Lange 1997: 544."},{"key":"e_1_2_6_29_2","first-page":"1614","article-title":"Intermittent heartburn and gastroesophageal reflux disease (GERD): effects of symptom frequency and severity on erosive mucosal changes","volume":"93","author":"Decktor D","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_30_2","unstructured":"WashingtonN.Antacids and Anti\u2010Reflux Agents. Boca Raton FL USA: CRC Press Inc 1991: 2."},{"key":"e_1_2_6_31_2","unstructured":"RitschelWA.Antacids and Other Drugs in GI Diseases. Hamilton IL USA: Drug Intelligence Publications Inc. 1984."},{"key":"e_1_2_6_32_2","unstructured":"WashingtonN.Antacids and Anti\u2010Reflux Agents. Boca Raton FL USA: CRC Press Inc. 1991: 127."},{"key":"e_1_2_6_33_2","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1001\/archinte.1987.00370080123022","article-title":"Ranitidine therapy for gastroesophageal reflux disease. Results of a large double\u2010blind trial","volume":"147","author":"Sontag S","year":"1987","journal-title":"Arch Intern Med"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-1263(199801\/02)18:1<3::AID-JAT461>3.0.CO;2-K"},{"key":"e_1_2_6_35_2","first-page":"S55","article-title":"The gastroduodenal mucus barrier and its role in protection against luminal pepsins: the effect of 16, 16 dimethyl prostaglandin E2, carbopol\u2013polyacrylate, sucralfate and bismuth subsalicylate","volume":"9","author":"Copeman M","journal-title":"J Gastroenterol Hepatol"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0031-6989(78)80058-7"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1996.22163000.x"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/12.Supplement_1.S3"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870100215"},{"key":"e_1_2_6_40_2","unstructured":"McDowellRH.Properties of Alginates. London UK: Alginate Industries Ltd 1968: 42."},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/0378-5173(94)90455-3"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0969-8051(88)80016-7"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/0378-5173(84)90159-5"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-5173(97)00266-4"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(73)80770-7"},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-5173(98)00143-4"},{"key":"e_1_2_6_47_2","first-page":"1940","article-title":"New principles in the treatment of reflux esophagitis in hiatal hernia","volume":"61","author":"Sandmark S","year":"1964","journal-title":"Svensk Lakartidn"},{"key":"e_1_2_6_48_2","first-page":"11","article-title":"Objective evaluation of an antacid with unusual properties","volume":"12","author":"Beckloff GL","year":"1972","journal-title":"J Clin Pharmacol"},{"key":"e_1_2_6_49_2","first-page":"45","article-title":"Anti\u2010reflux agents, stratification or floatation?","volume":"2","author":"Moss HA","year":"1990","journal-title":"Europ J Gastroenterol Hepatol"},{"key":"e_1_2_6_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/0378-5173(86)90238-3"},{"key":"e_1_2_6_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-5173(97)00372-4"},{"key":"e_1_2_6_52_2","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0016-5085(54)80029-1","article-title":"An in vitro evaluation of the efficacy of more frequently used antacids with particular attention to tablets","volume":"26","author":"Rossett NE","year":"1954","journal-title":"Gastroenterology"},{"key":"e_1_2_6_53_2","unstructured":"WashingtonN.Antacids and Anti\u2010Reflux Agents. Boca Raton FL USA: CRC Press Inc. 1991: 215."},{"key":"e_1_2_6_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/0378-5173(85)90076-6"},{"key":"e_1_2_6_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/0378-5173(86)90251-6"},{"key":"e_1_2_6_56_2","first-page":"1023","article-title":"The mode of action of alginic acid compound in the reduction of gastroesophageal reflux","volume":"20","author":"Malmud LS","year":"1979","journal-title":"J Nuc Med"},{"key":"e_1_2_6_57_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.1972.tb00816.x"},{"key":"e_1_2_6_58_2","first-page":"141","article-title":"A combined pH and X\u2010ray study of liquid alginate\/antacid formulation using a novel X\u2010ray contrast medium","volume":"3","author":"Goodall JS","year":"1977","journal-title":"Acta Therapeutica"},{"key":"e_1_2_6_59_2","first-page":"16","article-title":"Reflux esophagitis treated with Gaviscon","volume":"396","author":"Amdrup E","year":"1969","journal-title":"Acta Chir Scan Supplement"},{"key":"e_1_2_6_60_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1990.tb00509.x"},{"key":"e_1_2_6_61_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1998.00277.x"},{"key":"e_1_2_6_62_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1993.tb00132.x"},{"key":"e_1_2_6_63_2","unstructured":"WashingtonN.Antacids and Anti\u2010Reflux Agents. Boca Raton FL USA: CRC Press Inc. 1991: 224."},{"key":"e_1_2_6_64_2","unstructured":"WashingtonN.Antacids and Anti\u2010Reflux Agents. Boca Raton FL USA: CRC Press Inc. 1991:2156."},{"key":"e_1_2_6_65_2","unstructured":"WashingtonN.Antacids and Anti\u2010Reflux Agents. Boca Raton FL USA: CRC Press Inc. 1991: 223."},{"key":"e_1_2_6_66_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03259398"},{"key":"e_1_2_6_67_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1990.tb05348.x"},{"key":"e_1_2_6_68_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1018842503719"},{"key":"e_1_2_6_69_2","doi-asserted-by":"publisher","DOI":"10.1185\/03007998009110074"},{"key":"e_1_2_6_70_2","doi-asserted-by":"publisher","DOI":"10.1185\/03007997509114793"},{"key":"e_1_2_6_71_2","doi-asserted-by":"publisher","DOI":"10.1185\/03007997209111146"},{"key":"e_1_2_6_72_2","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1177\/030006057900700614","article-title":"The symptomatic treatment of heartburn and dyspepsia with Liquid Gaviscon: a muticentre general practitioner study","volume":"7","author":"Williams DL","year":"1979","journal-title":"J Int Med Res"},{"key":"e_1_2_6_73_2","first-page":"598","article-title":"Gaviscon in the treatment of reflux disease. Results of an observational study","volume":"108","author":"Von Hutt HJ","year":"1990","journal-title":"Fortschr Med"},{"key":"e_1_2_6_74_2","doi-asserted-by":"publisher","DOI":"10.1185\/03007999909114086"},{"key":"e_1_2_6_75_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1993.tb00111.x"},{"key":"e_1_2_6_76_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1995.tb03264.x"},{"key":"e_1_2_6_77_2","doi-asserted-by":"publisher","DOI":"10.1177\/030006058000800411"},{"key":"e_1_2_6_78_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1992.tb00572.x"},{"key":"e_1_2_6_79_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1976.tb140911.x"},{"key":"e_1_2_6_80_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007611-197801001-00004"},{"key":"e_1_2_6_81_2","first-page":"423","article-title":"Reflux esophagitis. A comparison of old and new medical management","volume":"74","author":"Grossman AE","year":"1973","journal-title":"J Kan Med Soc"},{"key":"e_1_2_6_82_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(74)92340-X"},{"key":"e_1_2_6_83_2","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1177\/014107689008300907","article-title":"Comparison of a dimethicone\/antacid (Asilone gel) with an alginate\/antacid (Gaviscon liquid) in the management of reflux oesophagitis","volume":"80","author":"Smart HL","year":"1990","journal-title":"J Roy Soc Med"},{"key":"e_1_2_6_84_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01307584"},{"key":"e_1_2_6_85_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01316854"},{"key":"e_1_2_6_86_2","doi-asserted-by":"crossref","unstructured":"BennettJR BucktonGK MartinHD SmithMR.The effect of adding cimetidine to alginate\u2010antacid in treating gastro\u2010esophageal reflux. In: Siewert JR Hosscher AH eds. Diseases of the Esophagus. Berlin: Springer Verlag 1988: 1111\u20135.","DOI":"10.1007\/978-3-642-86432-2_242"},{"key":"e_1_2_6_87_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.32.7.819"},{"key":"e_1_2_6_88_2","first-page":"C86","article-title":"Randomized double\u2010blind trial on the efficacy of algicon against ranitidine or a combination of both in peptic oesophagitis","volume":"56","author":"Van Avermaet S","year":"1993","journal-title":"Acta Gastroenterol Belg"},{"key":"e_1_2_6_89_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1998.0284f.x"},{"key":"e_1_2_6_90_2","first-page":"A350","article-title":"Time to onset of action of sodium alginate, ranitidine, omeprazole and water based on oesophageal pH","volume":"116","author":"Washington N","year":"1999","journal-title":"Gastroenterology"},{"key":"e_1_2_6_91_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1998.00283.x"},{"key":"e_1_2_6_92_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365528608996428"},{"key":"e_1_2_6_93_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365528509089662"},{"key":"e_1_2_6_94_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0011-3840(96)80012-8"},{"key":"e_1_2_6_95_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.1992.tb12189.x"},{"key":"e_1_2_6_96_2","first-page":"279","article-title":"Trial of Gaviscon in the treatment of gastro\u2010oesophageal reflux in infancy","volume":"8","author":"Weldon AP","year":"1972","journal-title":"Aust Paediat J"},{"key":"e_1_2_6_97_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02343223"},{"key":"e_1_2_6_98_2","first-page":"635","article-title":"Multicenter study of sodium alginate in the treatment of regurgitation in infants","volume":"39","author":"LeLuyer B","year":"1992","journal-title":"Ann Pediatr (Paris)"},{"key":"e_1_2_6_99_2","first-page":"346","article-title":"Treatment of childhood peptic oesophagitis with famotidine or alginate\u2010antacid","volume":"22","author":"Oderda G","year":"1990","journal-title":"Ital J Gastroenterol"},{"key":"e_1_2_6_100_2","doi-asserted-by":"publisher","DOI":"10.1185\/03007999909114087"},{"key":"e_1_2_6_101_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.67.5.618"},{"key":"e_1_2_6_102_2","doi-asserted-by":"publisher","DOI":"10.1016\/0028-2243(95)02069-1"},{"key":"e_1_2_6_103_2","first-page":"569","article-title":"Heartburn and regurgitation in pregnancy. efficacy and innocuousness of treatment with Gaviscon suspension","volume":"83","author":"Uzan M","year":"1988","journal-title":"Rev Fr Gynecol Obst"},{"key":"e_1_2_6_104_2","first-page":"48","article-title":"Comparative study of Algicon suspension and magnesium trisilicate mixture in the treatment of reflux dyspepsia of pregnancy","volume":"66","author":"Lang GD","year":"1990","journal-title":"Br J Clin Pract"},{"key":"e_1_2_6_105_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(97)00330-6"},{"key":"e_1_2_6_106_2","first-page":"289","article-title":"The association of asthma and gastroesophageal reflux: strategy of paraclinical studies","volume":"2","author":"Ramon P","year":"1985","journal-title":"Rev Mal Respir"},{"key":"e_1_2_6_107_2","doi-asserted-by":"publisher","DOI":"10.2165\/00044011-199918020-00004"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2000.00759.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2000.00759.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2036.2000.00759.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T13:46:35Z","timestamp":1698587195000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2036.2000.00759.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,6]]},"references-count":106,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2000,6]]}},"alternative-id":["10.1046\/j.1365-2036.2000.00759.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2036.2000.00759.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,6]]}}}